BioCentury | Dec 1, 2020
Product Development

U.K., South African data backup plan for Novavax in U.S.

...Editor A delay in starting the U.S. Phase III trial for its COVID-19 vaccine candidate means Novavax...
...president for R&D at Novavax Inc. (NASDAQ:NVAX), told BioCentury. Interim data from the U.K. trial, which Novavax...
...volunteers had underlying co-morbid medical conditions generally representative of the population,” Novavax reported. Glenn said Novavax...
BioCentury | Dec 1, 2020
Product Development

Moderna moves & Immunocore breaks through: a BioCentury podcast

...Usdin: The other things that I would bring up is the subunit protein vaccine from Novavax.[00:10:30]...
BioCentury | Nov 30, 2020
Product Development

Moderna says Warp Speed improved quality, but not speed of its COVID-19 vaccine development

...running now —ours, AstraZeneca’s, J&J’s, maybe Novavax’s...
...said. Steve Usdin Moderna Inc. Pfizer Inc. BioNTech SE AstraZeneca plc Johnson & Johnson Novavax Inc. U.S...
BioCentury | Nov 28, 2020
Product Development

U.S., U.K. volume bets on AZD1222 come into question with vaccine efficacy data

...data on protection from infection, the U.S. has procured a total of 300 million doses from Novavax Inc....
BioCentury | Nov 25, 2020
Product Development

Steady stream of Phase III COVID-19 vaccine data to flow into the new year

...months, Bharat’s trial could read out by 2Q21.Novavax Inc....
BioCentury | Nov 19, 2020
Product Development

EUAs for BioNTech-Pfizer, Moderna COVID-19 vaccines, readouts from AZ and J&J could come in December

...reported. Slaoui added that U.S. Phase III trials of recombinant adjuvanted protein vaccine candidates from Novavax Inc....
...produce vaccine doses at a commercial scale. Steve Usdin U.S. Food and Drug Administration (FDA) Pfizer Inc. BioNTech SE Moderna Inc. Novavax Inc. Johnson...
BioCentury | Nov 19, 2020
Product Development

COVID-19 vaccines that could report Phase III data before Moderna, Pfizer-BioNTech products become broadly available

...with the University of Oxford, uses a simian adenovirus vector dubbed ChAdOx1.Sanofi (Euronext:SAN; NASDAQ:SNY) and Novavax Inc....
...trial by year-end of its protein-based SARS-CoV-2 vaccine and to apply for EUA in 1H21. Novavax...
BioCentury | Nov 11, 2020
Management Tracks

Novavax brings in Tesaro’s Covino as it readies to market two vaccines; plus moves at Werewolf, Editas, Magenta, Pharming, Marinus and more

...By Danielle Golovin, Staff Writer Novavax Inc. (NASDAQ:NVAX) hired Gregory Covino as EVP and CFO as the company...
...of GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), where he also served as SVP and chief accounting officer. Novavax...
...as SVP of regulatory affairs. Johnson was SVP, head of regulatory and quality at Magenta. Danielle Golovin Novavax Inc. Editas...
BioCentury | Nov 10, 2020
Politics, Policy & Law

Bingham’s tenure with U.K. COVID vaccine task force drawing to a close

...said two of the vaccines, NVX-CoV2373 from Novavax Inc....
BioCentury | Nov 10, 2020
Product Development

New bar set by BioNTech, Pfizer COVID-19 vaccine could see swift influx of challengers

...hurdles. Vaccines with more established modalities, such as Novavax Inc....
Items per page:
1 - 10 of 492
BioCentury | Dec 1, 2020
Product Development

U.K., South African data backup plan for Novavax in U.S.

...Editor A delay in starting the U.S. Phase III trial for its COVID-19 vaccine candidate means Novavax...
...president for R&D at Novavax Inc. (NASDAQ:NVAX), told BioCentury. Interim data from the U.K. trial, which Novavax...
...volunteers had underlying co-morbid medical conditions generally representative of the population,” Novavax reported. Glenn said Novavax...
BioCentury | Dec 1, 2020
Product Development

Moderna moves & Immunocore breaks through: a BioCentury podcast

...Usdin: The other things that I would bring up is the subunit protein vaccine from Novavax.[00:10:30]...
BioCentury | Nov 30, 2020
Product Development

Moderna says Warp Speed improved quality, but not speed of its COVID-19 vaccine development

...running now —ours, AstraZeneca’s, J&J’s, maybe Novavax’s...
...said. Steve Usdin Moderna Inc. Pfizer Inc. BioNTech SE AstraZeneca plc Johnson & Johnson Novavax Inc. U.S...
BioCentury | Nov 28, 2020
Product Development

U.S., U.K. volume bets on AZD1222 come into question with vaccine efficacy data

...data on protection from infection, the U.S. has procured a total of 300 million doses from Novavax Inc....
BioCentury | Nov 25, 2020
Product Development

Steady stream of Phase III COVID-19 vaccine data to flow into the new year

...months, Bharat’s trial could read out by 2Q21.Novavax Inc....
BioCentury | Nov 19, 2020
Product Development

EUAs for BioNTech-Pfizer, Moderna COVID-19 vaccines, readouts from AZ and J&J could come in December

...reported. Slaoui added that U.S. Phase III trials of recombinant adjuvanted protein vaccine candidates from Novavax Inc....
...produce vaccine doses at a commercial scale. Steve Usdin U.S. Food and Drug Administration (FDA) Pfizer Inc. BioNTech SE Moderna Inc. Novavax Inc. Johnson...
BioCentury | Nov 19, 2020
Product Development

COVID-19 vaccines that could report Phase III data before Moderna, Pfizer-BioNTech products become broadly available

...with the University of Oxford, uses a simian adenovirus vector dubbed ChAdOx1.Sanofi (Euronext:SAN; NASDAQ:SNY) and Novavax Inc....
...trial by year-end of its protein-based SARS-CoV-2 vaccine and to apply for EUA in 1H21. Novavax...
BioCentury | Nov 11, 2020
Management Tracks

Novavax brings in Tesaro’s Covino as it readies to market two vaccines; plus moves at Werewolf, Editas, Magenta, Pharming, Marinus and more

...By Danielle Golovin, Staff Writer Novavax Inc. (NASDAQ:NVAX) hired Gregory Covino as EVP and CFO as the company...
...of GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), where he also served as SVP and chief accounting officer. Novavax...
...as SVP of regulatory affairs. Johnson was SVP, head of regulatory and quality at Magenta. Danielle Golovin Novavax Inc. Editas...
BioCentury | Nov 10, 2020
Politics, Policy & Law

Bingham’s tenure with U.K. COVID vaccine task force drawing to a close

...said two of the vaccines, NVX-CoV2373 from Novavax Inc....
BioCentury | Nov 10, 2020
Product Development

New bar set by BioNTech, Pfizer COVID-19 vaccine could see swift influx of challengers

...hurdles. Vaccines with more established modalities, such as Novavax Inc....
Items per page:
1 - 10 of 492